NO20063859L - Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter - Google Patents

Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter

Info

Publication number
NO20063859L
NO20063859L NO20063859A NO20063859A NO20063859L NO 20063859 L NO20063859 L NO 20063859L NO 20063859 A NO20063859 A NO 20063859A NO 20063859 A NO20063859 A NO 20063859A NO 20063859 L NO20063859 L NO 20063859L
Authority
NO
Norway
Prior art keywords
quinolone
medicaments
amino
carboxylic acid
acid derivatives
Prior art date
Application number
NO20063859A
Other languages
English (en)
Inventor
Elisabeth Defossa
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20063859L publication Critical patent/NO20063859L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System

Abstract

Det er beskrevet cykloalkylsubstituerte 7-amino-4-quinolon-3-karboksylsyrederivater samt deres fysiologisk godtakbare salter og fysiologisk funksjonelle derivater. Oppfinnelsen vedrører forbindelsene med formel (I), hvori resten har de angitte betydningene, samt deres fysiologisk godtakbare salter. Forbindelsene egner seg f.eks. som medikamenter for forebyggelse og behandling av diabetes type 2.
NO20063859A 2004-01-31 2006-08-29 Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter NO20063859L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004004971A DE102004004971B3 (de) 2004-01-31 2004-01-31 Cycloalkyl substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arnzeimittel
PCT/EP2005/000373 WO2005073231A1 (de) 2004-01-31 2005-01-15 Cycloalkyl substituierte 7-amino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
NO20063859L true NO20063859L (no) 2006-08-29

Family

ID=34813070

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063859A NO20063859L (no) 2004-01-31 2006-08-29 Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter

Country Status (15)

Country Link
EP (1) EP1713804B1 (no)
JP (1) JP4838730B2 (no)
KR (1) KR20060132672A (no)
CN (1) CN1910182A (no)
AT (1) ATE389654T1 (no)
AU (1) AU2005209368A1 (no)
BR (1) BRPI0507321A (no)
CA (1) CA2554527A1 (no)
DE (2) DE102004004971B3 (no)
IL (1) IL176915A0 (no)
MA (1) MA28340A1 (no)
MX (1) MXPA06007954A (no)
NO (1) NO20063859L (no)
RU (1) RU2006131307A (no)
WO (1) WO2005073231A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
CA2666219C (en) 2006-10-16 2017-02-07 Bionomics Limited Novel anxiolytic compounds
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2012116415A1 (en) 2011-03-02 2012-09-07 Bionomics Limited Novel small-molecules as therapeutics
WO2012120058A1 (de) 2011-03-08 2012-09-13 Sanofi Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120057A1 (de) 2011-03-08 2012-09-13 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
CA2835450C (en) 2011-05-12 2020-05-12 Bionomics Limited Methods for preparing naphthyridines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE239477T1 (de) * 1995-08-02 2003-05-15 Darwin Discovery Ltd Chinolone und deren therapeutische verwendung
GB0205165D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
DK1503759T3 (da) * 2002-05-14 2009-04-14 Univ California Substituerede quinoloncarboxylsyrer, deres derivater, virkningssted og anvendelser heraf

Also Published As

Publication number Publication date
MA28340A1 (fr) 2006-12-01
EP1713804B1 (de) 2008-03-19
MXPA06007954A (es) 2007-03-21
IL176915A0 (en) 2006-12-10
CN1910182A (zh) 2007-02-07
ATE389654T1 (de) 2008-04-15
BRPI0507321A (pt) 2007-06-26
AU2005209368A1 (en) 2005-08-11
WO2005073231A1 (de) 2005-08-11
JP2007519651A (ja) 2007-07-19
DE502005003310D1 (de) 2008-04-30
JP4838730B2 (ja) 2011-12-14
DE102004004971B3 (de) 2005-09-15
CA2554527A1 (en) 2005-08-11
KR20060132672A (ko) 2006-12-21
EP1713804A1 (de) 2006-10-25
RU2006131307A (ru) 2008-03-10

Similar Documents

Publication Publication Date Title
NO20063859L (no) Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
TNSN06409A1 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20085068L (no) Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20060870L (no) Fluorsubstituert omega-karboksyaryldifenylurea for behandling og profylakse av sykdommer og tilstander
TNSN06030A1 (en) Substituted thiazole-benzoisothiazole dioxide derivavites, method for the production thereof and use of the same
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
WO2006099943A8 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
RS20050019A (en) Heterocyclically substituted benzoylureas,method for their production and their use as medicaments
ATE433447T1 (de) Pyrimiidinverbindungen
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
TW200616985A (en) Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
NO20054418L (no) Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
MA27649A1 (fr) Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application